Literature DB >> 25332602

Unilateral Renal Vein Thrombosis and Adrenal Hemorrhage in A Newborn with Homozygous Factor V Leiden and Heterozygous Of MTHFR-677T, MTHFR-1298C Gene Mutations.

Gonca Sandal1, Elvan Arıkan1, Ayça Esra Kuybulu1, Ahmet Rifat Ormecı1.   

Abstract

Renal vein thrombosis (RVT) occurs as an acute and life-threatening event in neonates. RVT is the most common non-catheter-related thrombosis in infancy and occurs primarily in the newborn period. Non-catheter-related abdominal thrombosis on neonates has a higher incidence of genetic prothrombotic risk factors. RVT and adrenal hemorrhage can both be encountered in the neonatal period and they may occur at the same time (Bokenkamp et al., Eur J Pediatr 159:44-8, 2000; Lau et al. Pediatrics 120:1278-84, 2007). We report a case of unilateral RVT and adrenal hemorrhage in a newborn with homozygous factor V Leiden mutation and heterozygous of the methylene tetrahydrofolate reductase (MTHFR) gene mutations.

Entities:  

Keywords:  Adrenal hemorrhage; Homozygous factor V Leiden mutation; Newborn; Renal vein thrombosis

Year:  2014        PMID: 25332602      PMCID: PMC4192155          DOI: 10.1007/s12288-014-0364-6

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN: 0971-4502            Impact factor:   0.900


  13 in total

1.  Neonatal renal venous thrombosis in Germany between 1992 and 1994: epidemiology, treatment and outcome.

Authors:  A Bökenkamp; R von Kries; U Nowak-Göttl; U Göbel; P F Hoyer
Journal:  Eur J Pediatr       Date:  2000 Jan-Feb       Impact factor: 3.183

2.  [Neonatal renal vein thrombosis in a heterozygous carrier of both factor V Leiden and the MTHFR gene mutation].

Authors:  S Wannes; H Soua; S Ghanmi; H Braham; M Hassine; H A Hamza; H Ben Hamouda; M-T Sfar
Journal:  Arch Pediatr       Date:  2012-02-21       Impact factor: 1.180

3.  Neonatal renal venous thrombosis: clinical outcomes and prevalence of prothrombotic disorders.

Authors:  Stephen D Marks; M Patricia Massicotte; Brian T Steele; Douglas G Matsell; Guido Filler; Prakesh S Shah; Max Perlman; Norman D Rosenblum; Vibhuti S Shah
Journal:  J Pediatr       Date:  2005-06       Impact factor: 4.406

4.  Neonatal renal vein thrombosis and prothrombotic risk.

Authors:  S L Harris; M P Smith; A Laurie; B A Darlow
Journal:  Acta Paediatr       Date:  2010-02-11       Impact factor: 2.299

5.  Abdominal venous thrombosis in neonates and infants: role of prothrombotic risk factors - a multicentre case-control study. For the Childhood Thrombophilia Study Group.

Authors:  C Heller; R Schobess; K Kurnik; R Junker; G Günther; W Kreuz; U Nowak-Göttl
Journal:  Br J Haematol       Date:  2000-11       Impact factor: 6.998

6.  Renal vein thrombosis in a newborn with prothrombotic genetic risk factors.

Authors:  P Giordano; N Laforgia; G Di Giulio; S Storelli; A Mautone; A Iolascon
Journal:  J Perinat Med       Date:  2001       Impact factor: 1.901

7.  Renal vein thrombosis and adrenal hemorrhage in the newborn: ultrasound evaluation of 4 cases.

Authors:  C Orazi; G Fariello; S Malena; P Schingo; F Ferro; P Bagolan
Journal:  J Clin Ultrasound       Date:  1993 Mar-Apr       Impact factor: 0.910

8.  Perinatal renal venous thrombosis: presenting renal length predicts outcome.

Authors:  P J D Winyard; T Bharucha; R De Bruyn; M J Dillon; W van't Hoff; R S Trompeter; R Liesner; A Wade; L Rees
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2006-02-07       Impact factor: 5.747

9.  Renal venous thrombosis in neonates: prothrombotic risk factors and long-term follow-up.

Authors:  Andrea Kosch; Eberhard Kuwertz-Bröking; Christine Heller; Karin Kurnik; Rosemarie Schobess; Ulrike Nowak-Göttl
Journal:  Blood       Date:  2004-05-18       Impact factor: 22.113

10.  Renal venous thrombosis in a newborn with prothrombotic risk factors.

Authors:  Samar A Muwakkit; Raya Saab; Sami A Sanjad; Saleh I Bhar; Rim S Ishak; Zeina A Samad; Anthony K Chan; Miguel R Abboud
Journal:  Blood Coagul Fibrinolysis       Date:  2009-09       Impact factor: 1.276

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.